ANGIOS
Angios is a biotechnology company, specializing in vascular research to provide solutions for diabetic retinopathy.
ANGIOS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2021-01-01
Address:
Innsbruck, Tirol, Austria
Country:
Austria
Website Url:
http://www.angios-bio.com
Total Employee:
1+
Status:
Active
Contact:
43 512 319 76 2
Email Addresses:
[email protected]
Similar Organizations
Alzinova
Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.
ARNA Genomics
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
RITVERC GmbH
RITVERC GmbH is a company that specializes in research on radioisotopes for medicine and industry.
Official Site Inspections
http://www.angios-bio.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Angios"
Angios - Crunchbase Company Profile & Funding
Angios is a biotechnology company, specializing in vascular research to provide solutions for diabetic retinopathy. ... Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Organization. Angios . Connect to …See details»
Angios - Products, Competitors, Financials, Employees, …
Founded in 2021 and based in Innsbruck, Austria, Angios strives to develop new treatments for challenging vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by …See details»
Angios - 2025 Company Profile & Competitors - Tracxn
May 25, 2025 Angios is an unfunded company based in Innsbruck (Austria), founded in 2021 by Josef penninger and David Hoffmann. It operates as a Developer of therapeutics for multiple …See details»
Angios Biotech - Drug pipelines, Patents, Clinical trials - Synapse
Explore Angios Biotech with its drug pipeline, therapeutic area, technology platform, .See details»
Angios GmbH Overview | SignalHire Company Profile
Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. ... Organization Website: angios-bio.com : Angios GmbH industries Biotech: …See details»
Angios - Overview, News & Similar companies | ZoomInfo.com
Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new …See details»
Angios - VentureRadar
Website: https://www.angios-bio.com. Angios is developing new treatments for challenging vascular diseases using the vascular organoid model developed by the company’s founders. …See details»
Angios Biotech – Startups.Bio
May 21, 2021 To accelerate its therapeutic development, Angios has entered a multi-year, multi-target collaboration with AbCellera to facilitate the discovery of monoclonal and bispecific antibodies for vascular diseases of the eye. …See details»
Angios Biotech | Digital Health Corporate Profiles - HealthTech Alpha
Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new …See details»
AbCellera Partners with Angios to Develop Therapeutics to …
May 6, 2021 For more information, visit www.angios-bio.com. AbCellera Forward-looking Statements. This press release contains forward-looking statements, including statements …See details»
Angios Biotech - app.biopharmiq.com
About: Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop …See details»
Angios Biotech
Angios strives to develop new treatments for vascular diseases by pursuing pre-identified targets. We have developed a patented technology that allows for the generation of blood vessels of …See details»
Cooperation with panCELLa | Angio's Biotech
About Angios Based in Austria, Angios GmbH (Angios) is a biotechnology company specializing in developing therapeutics for vascular diseases with a vision of improving standard of care for …See details»
Angios Biotech
Angios is an Austrian biotechnology company, specializing in cell-based research. With our unique approach to target vascular diseases we want to improve patient's lives all over the …See details»
BIO 2025: Progress can't wait. | BIO - bio.org
1 day ago BIO 2025 started with a multi-panel session featuring officials from the Administration for Strategic Preparedness and Response (ASPR) and the Department of Defense about how …See details»
Drug Screening Platform - Angios Bio
However, no currently used animal model resembles accurately the human environment with their physiology, vascular organization, vessel composition and immune system as well as life …See details»
Angios | VentureRadar
Website: https://www.angios-bio.com. Angios is developing new treatments for challenging vascular diseases using the vascular organoid model developed by the company’s founders. …See details»
Welcome to BIO 2025: Collaboration can't wait. | BIO
2 days ago Massachusetts Gov. Maura Healey, the 2025 BIO Governor of the Year, believes in investing in biotech, and people.She’ll be receiving her award at BIO 2025 on Tuesday. …See details»
Vascular transplants - Angios Bio
Angios has developed a patented protocol to generatehuman blood vessels in a petridish. These “organoids” accurately recapitulate the composition and architecture of human micro …See details»
BIO International Convention Opens in Boston, Showcasing Global ...
2 days ago The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanity. BOSTON (June 16, 2025) The BIO …See details»